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A adição de 5-metil-2-tri-isopropilsililoxifurano (5) a N-carbobenziloxi-2-metoxipiperidina (6a)
forneceu uma mixtura dos isômeros eritro e treo 7a and 8a, respectivamente, em rendimentos de
moderado a bom (42-85%) e razão diastereoisomérica (7a : 8a) variando entre 1,1:1 – 6:1, dependendo
do sistema de solvente e do ácido de Lewis empregados. O isômero treo 8a foi transformado na
(+/-)-homopumiliotoxina 223G (1) que foi obtida a partir de 6a em 5 etapas e 13% de rendimento
total.
The addition of 5-methyl-2-triisopropylsilyloxyfuran (5) to N-carbobenzyloxy-2-
methoxypiperidine (6a) afforded a mixture of the corresponding erythro and threo isomers 7a and
8a, respectively, in moderate to good yields (42-85%) and diastereoisomeric ratio (7a : 8a) ranging
from 1.1:1 – 6:1 depending on the solvent system and the Lewis acid employed. The threo isomer 8a
was eventually converted to (+/-)-homopumiliotoxin 223G (1) which was prepared in 5 steps and
13% overall yield from 6a.
Keywords: homopumiliotoxin 223G, N-acyliminium ions, silyloxyfuran, vinylogous addition
Introduction
A wide range of biologically active compounds is found
in the skin secretions of amphibians. Many of these alkaloids
have unique profiles of pharmacological activities and
therapeutic potential. A remarkable variety of alkaloids have
been isolated from skin extracts of the frogs of the
Dendrobatidae family, which are used as antimicrobial agent
and chemical defense against predators. It appears likely
that all of the frog skin alkaloids are taken up from diet,
which for such amphibians consists mainly of small
arthropods.1 Homopumiliotoxins 223G (1), 235C, 319A,
319B and 321B (Figure 1) featuring a quinolizidine core
have been isolated in such minute amounts from
Dendrobatidae frogs which precluded the structural
elucidation of several representatives to be carried out.2
Prior to our efforts in this area, a single synthetic route
to homopumiliotoxin 223G (1) had been reported by
Kibayashi and coworkers3 along the synthetic scheme
depicted in Figure 2. The construction of the quaternary
stereogenic center was centered around the TiCl
4
-mediated
addition of allenylsilanes to a methyl ketone derived from
(S)-pipecolic acid. After hydrostannylation of the triple
bond and iodine-tin exchange, the construction of the
quinolizidine ring incorporating the (Z)-alkylidene side
chain was achieved through palladium-catalyzed
carbonylation of the vinyl iodide intermediate.3
Our approach to homopumiliotoxin 223 (1) is based
on the preparation of bicyclic lactam 2a through the
addition of 5-methylsilyloxyfuran 5 to an N-acyliminium
ion 4, followed by the installation of the (Z)-alkylidene
side chain based on a stereoselective aldol reaction
followed by stereospecific elimination (Figure 3).4
Figure 1. Representative homopumiliotoxins isolated from
Dendrobatidae frogs.
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Results and Discussion
As previously reported by Morimoto for the addition
of silyloxyfurans to 5-membered ring N-acyliminium ions,
we also observed that the diastereoselectivity was not
significantly affected by the nature of the Lewis acid,
except when TMSOTf was employed which afforded the





Additionally, the hitherto not observed regioisomer 9b
(relative configuration not determined) was formed when
N-Boc precursor of the N-acyliminium ion was employed
due to increased steric hindrance involving the methyl
group at C-5 in silyloxyfuran 5 and the N-Boc group (Table
1).
The relative configuration at the two newly generated
stereogenic centers was established after catalytic
hydrogenation of 7a,b and 8a,b, followed by methanolysis,
to give quinolizidinones 12 and 13, as illustrated below
for 7a and 8a (Scheme 1). Comparison of the nOe
experiments performed with quinolizidinones 12 (no
increment on H-9a upon irradiation of the methyl group at
C-1) and 13 (3.4% increment of the signal of H-9a upon
Figure 2. Synthetic approach to homopumiliotoxin 223 G (1) by Kibayashi and coworkers.
Figure 3. Synthetic approach to homopumiliotoxin 223G (1) based on vinylogous Michael addition to N-acyliminium ions.
Table 1. Addition of 5-methylsilyloxyfuran (5) to N-acyliminium ions
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a Diastereoisomeric ratio determined by GC and confirmed by 1H-
NMR analyses;b Yields determined after column chromatography
on silica gel of the crude product.
Scheme 1. Conversion of butenolides 7a and 8a to the correspond-
ing quinolizidinones 12 and 13.
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irradiation of the methyl group at C-1) allowed us to
establish the erythro relative configuration for the major
diastereoisomer 7a formed in the coupling reaction of 6a
and silyloxyfuran 5.
The stereochemical outcome of the above reaction came
to us as a surprise as previous results from our laboratory8
and elsewhere5 with 1-silyloxyfurans led us to predict the
preferential formation of the threo isomer. Additionally,
theoretical calculations of the transition state geometries
associated with the addition of 5-methylsilyloxyfuran 5 to
the N-acyliminium ion precursors at DFT level (B3LYP/3-
21G*) showed that array A (relative energy: 1.52 kcal mol-1)
displaying an antiperiplanar approach of the π systems of
the nucleophile and N-acyliminium ion leads to the lowest
energy transition state for the erythro isomer while array E
(relative energy: 0 kcal mol-1) with a synclinal arrangement
is prefered for the transition state leading to the threo isomer.
Martin and coworkers have found a similar result for the
transition state calculations (RHF/3-21G*) in the addition
of 2-methoxyfuran to 5-membered N-carbomethoxy-N-
acyliminium ion.7 Although at this point, we are not able to
rationalize the reversal of the stereochemical outcome
observed when 5-methyl-2-silyloxyfuran 5 was employed,
the unexpected preference for the erythro isomer may be
due to the steric hindrance posed by the methyl group at C-
5 which has not being properly taken into account in the
DFT calculations.
The addition of 5-methylsilyloxyfuran 5 to the N-
acyliminium ion derived from chiral 2-methoxypiperidine
carbamate 6c (Scheme 2) afforded butenolide 7c as the
major diastereoisomer (diastereoisomeric ratio 12:1
determined by capillary GC analysis). Surprisingly, the
regioisomer 9c (relative configuration not determined) was
formed upon changing the order of addition of the reagents:
whereas none of regioisomer 9c was observed when TiCl
4
was added to a solution of methoxycarbamate 6c in
dichloromethane, followed by the addition of
silyloxyfuran 5, significant amounts were formed when
the Lewis acid was added to a mixture of 6c and 5.
The relative configuration at the two newly generated
stereogenic centers was established after catalytic
hydrogenation to 10c, followed by methanolysis to give
quinolizidinone 12 and the recovery of the chiral auxiliary.
However, the absolute configuration has not being
unambiguously established yet. The Si-face selectivity of
the chiral N-acyliminium ion derived from 6c was proposed
based on our previous results with 8-phenylmenthyl chiral
auxiliaries8 and was rationalized through the kinetically
preferred attack of the nucleophile to the s-cis
conformation of N-acyliminium ions (Scheme 2),9 that
might be enforced by π-stacking interactions10 involving
Figure 4. Transition state models for the formation of erythro-7a
and threo-8a.
Scheme 2. Proposed facial discrimination in the addition of 5 to the N-acyliminium ion derived from 2-methoxycarbamate 6c (*the absolute
configuration may be the opposite as shown).
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the low-lying LUMO of the carbamoyl group and HOMO
of the phenyl substituent.
Assembly of quinolizidinone 13, the requisite precursor
for the preparation of homopumiliotoxin 223G (1), was
achieved from butenolide 8a in 76% overall yield (Scheme
1) which was best prepared through the reaction of 2-
methoxycarbamate 6a and 2-triisopropylsilyloxy-5-




 at –78 oC promoted by TiCl
4
(Table 1, entry 2). Under these conditions, a mixture
(1.2:1.0) of butenolides 7a:8a (70% combined yield) was
formed which afforded 8a in 32% yield, after separation
by column chromatography on silica gel.
The construction of the (Z)-alkylidene side chain and the
synthesis of homopumiliotoxin 223G (1)
With an access to the heterocyclic core of
homopumiliotoxin 223G secured, we focused on the aldol
reaction as the central strategy to install the (Z)-alkylidene
side chain characteristic of this family of alkaloids. In order
to evaluate the stereochemical outcome of the aldol
reaction of lithium enolates derived from six-membered
lactams, we first examined the addition of the lithium
enolate of readily available N-ethyl-δ-valerolactam,
(prepared in 96% yield from δ-valerolactam and ethyl
iodide) to isobutyraldehyde. The reaction of its lithium
enolate (generated in THF at –78 °C with LDA or LiHMDS)
with isobutyraldehyde afforded two aldol products
14a:14b in 3.9:1 ratio and 75% yield when LDA was
employed and 4.4:1 ratio and 60% yield with LiHMDS.
The determination of diastereoisomeric ratio was achieved
by GC and confirmed by 1H-NMR. The relative
configuration of the major diastereoisomer was tentatively
assigned at this point as anti-14a based on the magnitude
of the coupling constant (9.2 Hz) between H-3 and H-1'
and the relative shielding of C-3 and C-1' (δ 44.0 and 76.3,
respectively) in the major adduct as compared to the minor
one (δ 44.8 and 76.6, respectively). The deshielding of the
hydroxylic hydrogen in the 1H-NMR spectrum of 14a
(δ 5.90) and the lower stretching frequencies of the
hydroxyl and carbonyl groups (3338 and 1610 cm-1,
respectively) in 14a as compared to 14b (3423 and 1622
cm-1, respectively) are consistent with a hydrogen-bonded
hydroxyl group in 14a.
The relative stereochemistry was eventually esta-
blished after syn elimination carried out under the
conditions described by Corey and coworkers.11 Treatment
of the major diastereoisomer 14a with dicyclohexyl-
carbodiimide (DCC) and cuprous chloride in refluxing
toluene stereospecifically provided (E)-isobutylidene
piperidinone 15a in 88% yield, while under the same
conditions (Z)-isobutylidene piperidinone 15b was formed
in 87% yield from the minor aldol adduct 14b.
The relative configuration of the isobutylidene
piperidinones 15a and 15b could be straigthforwardly
assigned by inspection of the corresponding 1H-NMR
spectra, particularly from the H-1’ signal which appeared
deshielded in 15a (δ 6.65) in comparison with 15b (δ 5.49)
as the result of the anisotropic effect of the carbonyl group.
Next we evaluated the reaction of the preformed lithium
enolate of quinolizidinone 13 with isobutyraldehyde
which produced a 20:1 mixture of two aldol adducts
16a:16b in 85% yield, as depicted in Scheme 5. Only two
out of the four possible stereoisomers were formed. The
syn and anti stereochemistries were assigned by analogy
to the above results. Moreover, an outstanding selectivity
was observed: the diastereoisomeric ratio was determined
by GC and 1H-NMR to be 20:1 and 32:1 for the lithium-
and titanium (IV)-mediated reactions, respectively.
 The relative configuration of the two newly created
stereogenic centers was unequivocally established after
syn elimination to the corresponding isobutylidene
derivatives. Treatment of the major aldol product anti-
16a with DCC and cuprous chloride in refluxing toluene
afforded (E)-17 in 95% yield while (Z)-17 was formed in
95% yield from the minor aldol adduct syn-16b. The
assignment of the configuration of the double bond wasScheme 3. Aldol reaction of lithium enolate of N-ethyl-δ-valerolactamwith isobutiraldehyde.
Scheme 4. Model studies of syn elimination with 14a and 14b.
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possible upon inspection of the 1H-NMR spectra which
displayed H-1’ deshielded in (E)-17 (δ 6.81) when
compared to (Z)-18 (δ 5.60). Alternatively, Mukaiyama
aldol reaction of the N,O-silylketene acetal derived from
1312 let to a reversal in the stereochemical outcome and
aldol syn-16b was formed as the major isomer (3:1 mixture
of syn-16b:anti-16a) in 70% yield, Scheme 5.
The high diastereoselection observed in the aldol
reactions with lithium and titanium (IV) enolates led us to
consider that these metal enolates provided highly
selective aldol reaction under chelation control according
to a Zimmerman-Traxler model (Scheme 7). The formation
of diastereoisomers anti-16a and syn-16b was accounted
for based on the approach of the aldehyde cis to the
lithiated hydroxyl group of quinolizidinone 13.
Thus, the relative stereochemistry of the aldol adduct
lactam at C-3 and C1’ was generated by the attack of the
enolates into the aldehyde through its concave face. These
results could be rationalized by the preformed quaternary
lithium alkoxide in the enolate formation step, stabilizing
the quinolizidinone enolate through a possible lithium
dimer interaction, affording anti-16a preferentially due to
the relief of the steric hindrance involving the isopropyl
group which is axially positioned in the transition state
model leading to syn-16b (Scheme 7). Theoretical analysis
through geometry optimization of the possible conformers
of anti-16a using DFT method (B3LYP/STO-3G,
Gaussian98 program),13 as well as the semi empiric methods
PM3 and AM1, showed an increase in the stability ranging
from 1.8 to 4 kcal/mol when a hydrogen bond involving
the carbonyl and hydroxyl groups is present. Additionally,
geometry optimization using semi-empirical and ab initio
Scheme 5. Aldol reaction of lithium, titanium(IV) and silicon enolates
of 13 with isobutyraldehyde.
Scheme 6. syn-Elimination from anti-16a and syn-16b.
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(DFT) methods showed that anti-16a is more stable by
0.39 (using PM3), 2.18 (using AM1) and 8.39 kcal mol-1
(using DFT) than its corresponding epimer at C-3 and C-1’
which would require cis approach of the aldehyde to the
methyl group at the quaternary center through a
Zimmerman-Traxler transition state.
The preferential formation of syn-16b when the N,O-
silylketeneacetal from quinolizidinone 13 was employed
(Mukaiyama conditions) may be rationalized through a
preferential open transition state model with antiperiplanar
approach of the N,O-silylketeneacetal to the aldehyde so
as to relieve the steric strain between the isopropyl group
of the aldehyde and the quinozilidine ring (Scheme 7).
At this point, we needed to secure an efficient and
stereospecific anti elimination methodology in order to
benefit from the highly stereoselective formation of anti-
16a when the lithium or titanium(IV) enolates were
employed (Scheme 5) and we that goal in mind several
reaction conditions were investigated.
Initially, we employed anti-14a as our model
compound and the results are summarized in Scheme 8.
The conversion of anti-14a to the corresponding mesylate
19, followed by elimination in refluxing pyridine provided
only (E)-15a. The same stereochemical outcome was




Cl, py, 0 °C to rt; 2.
HCl; 3. MeOH/ KOH, reflux) (Scheme 8, equation 2).
Reasoning that the preferential formation of (E)-15a
resulted from a competitive ElcB mechanism which would
be enforced over the expected E2 by polar solvents, we
decided to investigate elimination of 19 in hexane with
DBU as base. Compared to bases such as pyridine, this
amidine base (DBU) is particularly effective in promoting
elimination reactions.14 In fact, under these conditions a
3:1 mixture of stereoisomers 15a:15b was formed in 88%
yield (Scheme 8, equation 3).The exclusive formation of
Scheme 7. Zimmerman-Traxler and Mukaiyama transition state
models for aldol reactions with quinolizidinone 13.
Scheme 8. Model study for stereospecific anti elimination of anti-14a.
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stereoisomer 15b was eventually achieved using Stork
protocol,15 suggesting that only E2 mechanism was
operative under these experimental conditions (Scheme
8, equation 4).
The preference for the formation of (E)-isobutylidene
side chain was also observed when anti-16a was submitted
to the conditions described by Gallagher et al.16 which
provided (E)-17 in 83% yield. However, as observed above
for anti-14a, under Stork conditions only the desired (Z)-
isomer 18 was formed in 80% yield (Scheme 9).
(Z)-Alkylidenelactam 18 was then reduced with alane
and after acidification with methanolic HCl, homo-
pumiliotoxin 223G (1) was isolated as the corresponding
hydrochloride salt in 82% yield (Scheme 10).
The vinylogous Michael addition of silyloxyfuran 5
to α-methoxycarbamate 6a was employed in the total
synthesis of (±)-homopumiliotoxin 223G (1) alkaloid
which was accomplished in 5 steps and 13% overall yield.
The approach may find good use also in the preparation of
indolizidine alkaloids and provide a good solution to the
installation of the (Z)-alkylidene side chain in heterocyclic
systems. Additionally, our initial results on the asymmetric
version of the vinylogous Mannich reaction employing
chiral carbamate 6c may be considered for the preparation
of the asymmetric version by the route described above.
Scheme 10. Conversion of 18 to (+/-)-homopumiliotoxin 223G
(1).HCl.
Scheme 9. Stereospecific elimination from anti-16a.
Experimental
General
All experiments were carried out under an argon
atmosphere except for hydrolysis under acid conditions.
Dichloromethane was distilled from CaH
2
, tetrahydrofuran
previously treated with CaH
2
 and distilled from sodium,
methanol was distilled from Mg tunnings. The normal
extracts consisted of drying over MgSO
4
, filtration and
concentration under reduced pressure with a rotatory
evaporator. The compounds were purified by column
chromatography on silica gel (70-230 mesh). The 1H-NMR
and 13C-NMR spectra were recorded on a Varian Gemini
(7.05T), Varian Inova (11.7T) spectrometers. Chemical
shifts (δ) are recorded in ppm with the solvent resonance
as the internal standard and coupling constants (J) recorded
in Hz. Signals for rotational and/or configuration isomers
are denoted inside brackets. The infrared spectra were
recorded as films in KBr cells on a Nicolet Impact 410
(FTIR). High resolution mass spectroscopy (HRMS) were
performed on a Autoespec-Micromass-EBE. Optical
rotations were measured on a polarimeter Polamat A Carl
Zeiss Jena using a quartz cell and a mercury or sodium
lamp. The melting points were measured on an
Eletrothermal 9100 apparatus. The gas chromatography
analyses (FID detector) were performed using a HP-5890-
II equipament. Gas chromatography-mass spectrometry
(GC-MS) analyses were performed on a Hewlett Packard
5890/ Hewlett Packard 5970 MSD.
Benzyl (2R*)-2-[(2S*)-2-methyl-5-oxo-2,5-dihydro-2-
furanyl]hexahydro-1- pyridinecarboxylate (7a) and benzyl
(2R*)-2-[(2R*)-2-methyl-5-oxo-2,5-dihydro-2-
furanyl]hexahydro-1-pyridinecarboxylate (8a)
To a solution of metoxycarbamate 6a18 (0.18 mmol,




 (1.00 mL) at –78 °C was
added TiCl
4
 (0.18 mmol, 0.020 mL) and the black mixture
was stirred for 30 min. under argon atmosphere, followed by
slow addition of 2-(5-methyl)-triisopropylsilyloxyfuran 519




 (0.10 mL). After 30 min
saturated aqueous NH
4
Cl (1.00 mL) was added and the layers





 (2x 5 mL), and the combined organic phase was
dried over MgSO
4
 and concentrated under reduced pressure.
The crude was submitted to flash column chromatography
purification (hexane/ethyl acetate, 2:1) affording 7a (0.022
g, 0.069 mmol) and 8a (0.018 g, 0.057 mmol) in a 1.2:1
diastereoisomeric mixture, in 70% combined yield. 7a. 1H-
RMN (500 MHz, CDCl
3
) δ 1.20-1.26 (1H, m), 1.43 (3H, s),
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1.45-1.60 (2H, m), 1.68-1.88 (3H, m), 3.14-3.26 (1H, m),
4.14 (0.75H, bd, J 11.7 Hz), 4.25 (0.25H, bd, J 11.7 Hz),
4.38 (0.44H, m), 4.55 (0.56H, d, J 6.1 Hz), 5.04-5.22 (2H, m,
J 3.7 Hz), 6.10 (1H, bd, J 5.6 Hz), 7.29-7.40 (5H, m), 7.42














), 93.2 (C), 121.0 (CH), 127.7 (2xCH), 128.1
(CH), 128.5 (2xCH), 136.8 (C), 159.8 (C), 160.2 (CH), 172.5
(C). IR (NaCl film) ν
max
 /cm-1: 1765, 1689. GC-MS (EI) m/z:
218(8%), 174(23%), 91(100%). 8a. 1H-RMN (500 MHz,
CDCl
3
) δ: 1.19-2.11 (6H, m), 1.41 (3H, s), 2.82 (1H, m), 3.91
(1H, dd, J 12.9, 3.9 Hz), 4.98 (1H, d, J 2.0 Hz), 5.02 (2H, dd,
J 15.1, 12.0 Hz), 5.74 (1H, d, J 5.1 Hz), 7.20-7.30 (5H, m),














), 93.4 (C), 119.4 (CH), 127.9 (2xCH), 128.3
(CH), 128.7 (2xCH), 136.8 (C), 156.3 (C), 160.8 (CH), 173.1
(C). IR (NaCl film) ν
max
 /cm-1: 2949, 1765, 1697. GC-MS





 /cm-1: 3365, 3086, 3064, 2976, 2937,
2871, 1768, 1689, 1452, 1414, 1369, 1275, 1250, 1152,
1034, 957, 822, 768. 1H-RMN (300 MHz, CDCl
3
) δ 1.41
(3H, d, J 2.5 Hz), 1.46 (9H, s), 1.24-1.53 (4H, m), 1.52-1.67
(1.8H, m), 1.98 (0.2H, dt, J 1.5, 7.0 Hz), 2.70-3.12 (1H, m),
3.48-3.88 (0.2H, m), 3.99 (0.6H, bd, J 13.6 Hz), 4.09-4.13
(0.2H, m), 4.31 (0.4H, m), 4.50 (0.6H, m), 6.07 (1H, d, J 5.5
















), 52.7 (CH), 79.9 (C), 93.4 (C), 120.9
(CH), 160.4 (C), 160.8 (CH), 172.2 (C). HRMS (EI): found











 /cm-1: 3105, 2974, 2937, 2864, 1795, 1697,
1452, 1412, 1367, 1162. 1H-RMN (300 MHz, CDCl
3
) δ 1.34-
1.38 (9H, m), 1.48-1.59 (5H, m), 1,70 (0.5H, m), 1,89 (0.9H,
d, J 1.5 Hz), 1.90 (0.9H, d, J 1.5 Hz), 1.91 (0.6H, d, J 1.5 Hz),
1.92 (0.6H, d, J 1.5 Hz), 2.19 (0.5H, bd, J 9.2 Hz), 2.66 (1H,
m), 3.46 (0.3H, dt, J 1.5, 7.7 Hz), 3.58 (0.7H, dt, J 2.2, 7.7
Hz), 4.00 (1H, m), 4.25 (1H, m), 4.88 (0.32H, s), 5.01(0.68H,
t, J 1.5 Hz). 13C-RMN (75 MHz, CDCl
3














44.8 (CH), 52.5 (CH), 80.4 (C), 102.1 (CH), 153.1 (C), 154.6







 (M+•- tBu): 224.0923.
( 1 R , 2 S , 5 R ) - 5 - M e t h y l - 2 - ( 1 - m e t h y l - 1 -
phenylethyl)cyclohexyl (2R)-2-[(2S)-2-methyl-5-oxo-2,5-
dihydro-2-furanyl]hexahydro-1-pyridinecarboxylate (7c)
The same procedure described for 7a was employed,





). IR (KBr) ν
max
 /cm-1: 3086, 3057, 3016, 2959,
2870, 1768, 1689, 1670, 1601, 1423, 1379, 1338(m),
1263(m), 1161(m), 1034, 957, 926, 822, 760, 700. 1H-RMN
(500 MHz, CDCl
3
) δ 0.81 (6H, d, J 6.6 Hz), 0.84-0.91 (1H,
m), 1.13 (3H, t, J 22.0 Hz), 1.37 (1H, s), 1.32-1.54 (3H, m),
1.57-1.72 (3H, m), 1.81-1.89 (1H, m), 1.93-2.11 (3H, m),
2.52 (1H, dt, J 2.4, 13.7 Hz), 2.91-2.98 (2H, m), 4.04-4.07
(1H, m), 4.37 (1H, d, J 5.4 Hz), 4.69 (1H, dddd, J 20.0, 9.0,
3.9, 3.9 Hz), 5.98 (1H, dd, J 5.6, 28.1 Hz), 7.03-7.10 (1H,
m), 7.20 (3H, bd, J 5.6 Hz), 7.18-7.27 (1H, m), 7.32 (1H, d,
J 5.6 Hz). 13C-RMN (125 MHz, CDCl
3

























), 50.5 (CH), 53.5 (CH), 75.9 (CH), 93.1 (CH),
120.8 (CH), 125.0 (CH), 125.0 (CH), 125.1 (CH), 128.0
(CH), 128.1 (CH), 152.1 (C), 155.3 (C), 160.3 (CH), 172.6













( 1 R , 2 S , 5 R ) - 5 - M e t h y l - 2 - ( 1 - m e t h y l - 1 -
phenylethyl)cyclohexyl 2-(5-methyl-2-oxo-2,3-dihydro-3-
furanyl)-1-piperidinecarboxylate (9c)
mp 136.4-137.3 °C. IR (KBr) ν
max
 /cm-1: 3087, 3057,
2943, 2864, 2723, 1795, 1689, 1670, 1460, 1425, 1263,
1171, 1113, 1093, 1030, 939, 881, 850, 764. 1H-RMN
(500 MHz, CDCl
3
) δ 0.77 (6H, d, J 6.6 Hz), 0.82-0.93 (1H,
m), 0.96 (4H, s), 1.12 (1H, s), 1.23 (1H, d, J 3.4 Hz), 1.31-
1.39 (8H, m), 1.79 (0.83H, s), 1.87 (2.17H, s), 1.82-1.93
(1H, m), 2.17 (0.73H, bd, J 13.4 Hz), 2.24 (0.27H, bd, J
13.4 Hz), 2.47 (0.66H, bt, J 12.7 Hz), 2.64 (0.34H, bt, J
12.7 Hz), 3.14 (0.87H, bd, J 11.7 Hz), 3.34 (0.13H, m), 3.52
(0.73H, bd, J 10.0 Hz), 3.65 (0.27H, bd, J 10.0 Hz), 3.98
(0.04H, bd, J 9.8 Hz), 4.12 (0.08H, bd, J 9.8 Hz), 4.15
(0.08H, bdd, J 4.0, 9.8 Hz), 4.33 (0.80H, d, J 9.8 Hz), 4.63-
4.68 (1H, m), 4.74 (0.65H, s), 4.95-4.97 (0.35H, m), 7.01-
7.07 (1H, m), 7.17 (2H, d, J 2.9 Hz), 7.19 (2H, d, J 2.2 Hz).
13C-RMN (125 MHz, CDCl
3


















), 31.2 (CH), 34.6 (CH
2
), 39.2 (CH), 39.3 (CH
2
),
39.8 (C), 42.4 (CH
2
), 50.5 (CH), 51.9 (CH), 75.6 (CH), 101.8
(CH), 125.0 (CH), 125.3 (CH), 125.4 (CH), 125.7 (CH),
127.8 (CH), 127.9 (C), 151.8 (C), 154.7 (C), 177.5 (C).
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Benzyl (2R*)-2-[(2S*)-2-methyl-5-oxotetrahydro-2-
furanyl]hexahydro-1-pyridinecarboxylate (10a)
To a solution of 7a (0.019 g, 0.060 mmol) in ethyl
acetate (0.60 mL) was added Pd/C (10%) (0.0019 g) and
the mixture was stirred under H
2
 (1 atm) for 4 h. The mixture
was then filtered through Celite, and the pad was rinsed
with EtOAc/MeOH (4:1, 10 mL). The organic layer was
concentrated under reduced pressure to furnished pure 10a
as a colorless oil in 99% yield (0.011 g, 0.059 mmol). 1H-
RMN (300 MHz, CDCl
3
) δ 1.02-1.41 (2H, m), 1.30 (3H, s),
1.49-1.57 (2H, m), 1.64-1.70 (1H, m), 1.72-1.84 (1H, m),
2.43-2.60 (5H, m), 2.68 (1H, dd, J 11.4, 2.0 Hz), 3.04 (1H,
dl, J 1.4 Hz). 13C-RMN (75 MHz, CDCl
3
















), 63.0 (CH), 89.0 (C), 176.8 (C). IR (KBr film)
ν
max







 (M+•) : 183.1259.
( 1 R , 2 S , 5 R ) - 5 - M e t h y l - 2 - ( 1 - m e t h y l - 1 -
phenylethyl)cyclohexyl (2R)-2-[(2S)-2-methyl-5-
o x o t e t r a h y d r o - 2 - f u r a n y l ] h e x a h y d r o - 1 -
pyridinecarboxylate (10c)
To a solution of 7c (0.060 mmol) in ethyl acetate (0.60
mL) was added Pd/C (10%) (0.0019 g) and the mixture
was stirred under H
2
 (2.5 psi) for 4 h. The mixture was then
filtered through Celite, and the pad was rinsed with EtOAc/
MeOH (4:1, 10 mL). The organic layer was concentrated
under reduced pressure to furnished pure 10c as a colorless
oil in 99% yield (0.059 mmol). [α]
Hg





 /cm-1: 2954, 2927, 2870, 1774, 1682, 1425,
1385, 1340, 1261, 1180, 1132, 1034, 978, 945, 762, 702.
1H-RMN (500 MHz, CDCl
3
), δ 0.81 (6H, d, J 5.5 Hz), 0.79-
1.04 (1H, m), 1.13 (3H, t, J 5.0 Hz), 1.28 (3H, d, J 26.0 Hz),
1.11-1.47 (9H, m), 1.49-1.69 (4H, m), 1.71-1.80 (1H, m),
1.82-2.06 (1H, m), 2.10-2.17 (1H, m), 2.41 (1H, dt, J 13.7,
2.4 Hz), 2.43-2.61 (2H, m), 2.91 (1H, bd, J 20.1 Hz), 4.04-
4.12 (1H, m), 4.66 (1H, dddd, J 20.1, 10.7, 4.15, 3.7 Hz),
7.05-7.08 (1H, m), 7.17-7.25 (4H, m). 13C-RMN (125 MHz,
CDCl
3
























), 39.5 (C), 42.1 (CH
2
),
50.5 (CH), 55.9 (CH), 75.8 (CH), 90.0 (C), 124.5 (CH),
124.8 (CH), 125.1 (CH), 128.0 (CH), 128.1 (CH), 152.1
(C), 155.5 (C), 176,8 (C).
Benzyl (2R*)-2-[(2R*)-2-methyl-5-oxotetrahydro-2-
furanyl]hexahydro-1-pyridinecarboxylate (11a)
The same procedure described for 10a was employed
using 8a, affording 11a in 98% yield. 1H-RMN (300 MHz,
CDCl
3
) δ 1.11-1.29 (1H, m), 1.32 (3H, s), 1.53-1.57 (2H,
m), 1.79-1.90 (2H, m), 2.08-2.18 (1H, m), 2.45-2.66 (6H,















), 64.8 (CH), 88.8
(C), 176.5 (C). IR (KBr film) ν
max
 /cm-1: 1770. HRMS (EI):






 (M+•) : 183.1259.
(1S*,9aR*)-1-Hydroxy-1-methylperhydro-4-quinolizinone (12)
A solution of MeONa/MeOH (1.1 mol L-1, 2.7 mL) was
added to 10a (0.083 g, 0.45 mmol) at 0 °C, and the mixture
was stirred at room temperature. After 2 h, 1.0 mL of HCl/
MeOH solution (2 mol L-1) was carefully added. The
organic layer was concentrated under reduced pressure,
providing 12 in 93% yield as a white solid (0.077 g, 0.42
mmol). mp 133.2-134.3 °C. 1H-RMN (500 MHz, CDCl
3
),
δ 1.14 (1H, dq, J 12.5, 3.9 Hz), 1.20 (3H, s), 1.36 (1H, dt,
J 12.7, 3.9 Hz), 1.47 (1H, tq, J 12.9, 3.9 Hz), 1.57 (1H, bd,
J 9.0 Hz), 1.67 (1H, ddd, J 11.7, 3.4, 1.5 Hz), 1.76 (1H, dd,
J 12.7, 2.7 Hz), 1.82 (1H, ddd, J 11.5, 6.1 Hz), 1.88 (1H, bd,
J 10.5 Hz), 2.29 (1H, ddd, J 18.0, 6.1, 4.0 Hz), 2.35 (1H, dt,
J 13.0, 2.9 Hz), 2.54 (1H, ddd, J 18.0, 11.5, 7.09 Hz), 3.08
(1H, bd, J 2.2 Hz), 3.42 (1H, bs), 4.69 (1H, dddd, J 13.0,
















), 68.1 (CH), 69.5 (C), 168.1 (C). IR (KBr film)
ν
max







 (M+•) : 183.1259.
(1R*,9aR*)-1-Hydroxy-1-methylperhydro-4-quinolizinone (13)
The same procedure was employed from 11a, affording
13 in 78% yield, as an yellow sirup. 1H-RMN (500 MHz,
CDCl
3
), δ 1.33 (3H, s), 1.36 (2H, bt, J 14.4Hz), 1.44 (1H, dq,
J 13.2, 3.2 Hz), 1.64 (1H, dd, J 11.9, 2.5 Hz), 1.76 (1H, ddd,
J 16.6, 10.7, 5.6 Hz), 1.89 (2H, m), 1.95 (1H, m), 2.34 (1H,
t, J 5.4 Hz), 2.41 (1H, dt, J 11.5, 4.2 Hz), 2.62 (1H, ddd, J
16.1, 10.7, 5.6 Hz), 3.07 (1H, bdd, J 11.3, 2.5 Hz), 3.45 (1H,
sl), 4.79 (1H, dddd, J 17.1, 2.0, 2.0, 2.0 Hz). 13C-RMN (125
MHz, CDCl
3















), 65.5 (CH), 67.9
(C), 169,1 (C). IR (KBr film) ν
max
 /cm-1: 1614. HRMS (EI):







( 3 S * ) - 1 - E t h y l - 3 - [ ( 1 S * ) - 1 - h y d r o x y - 2 -
methylpropyl]hexahydro-2-pyridinone (14a) and (3S*)-1-
ethyl-3-[(1R*)-1-hydroxy-2-methylpropyl]hexahydro-2-
pyridinone (14b)
n-Butyllithium (0.751 mL, 2.2 mol L-1 solution in
991Studies Towards the Construction of Alkylidene QuinolizidinesVol. 14, No. 6, 2003
hexane) was added to a solution of diisopropylamine (0.167
g, 1.65 mmol) in dry THF (14.5 mL) at –78 °C under argon
atmosphere. The mixture was stirred for 30 min. at 0 °C,
then cooled to –78 °C, followed by slow addition of N-
ethylvalerolactam (0.100 g, 0.787 mmol) in 3.0 mL of dry
THF. The mixture was warmed to 0 °C and stirred for 1 h.
Isobutyraldehyde (0.0624 g, 0.866 mmol) was added at –
78 °C and warmed to 0 °C. After 30 min, NH
4
Cl (2.0 mL)
was added. The organic layer was separated, and the
aqueous phase was extracted with AcOEt (3x 30 mL). The
combined organic layer was dried over MgSO
4
, filtered
and concentrated under reduced pressure, affording a 3.9:1
mixture of 14a:14b in 75% yield. The mixture of
diastereoisomers was separated by flash chromatography
(hexane:AcOEt, 1:1) providing pure 14a (0.0935 g,
0.470 mmol, 60%) and 14b (0.0239 g, 0.120 mmol, 15%)
as white crystals. 14a. mp:34.3-35.4 °C 1H-RMN (CDCl
3
,
300 MHz) δ 0.88 (3H, d, J 6.6 Hz), 1.05 (3H, d, J 6.6 Hz),
1.13 (3H, t, J 7.3 Hz), 1.34-1.47 (1H, m), 1.72-1.83 (4H, m),
1.84-1.96 (2H, m), 2.26 (1H, ddd, J 11.4, 9.5, 5.9 Hz), 3.28-
3.33 (2H, m), 3.39 (2H, dq, J 7.3, 3.6 Hz), 3.58 (1H, dd, J
9.2, 2.6 Hz), 5.90 (1H, s). 13C-RMN (CDCl
3












29.0 (CH), 42.1 (CH
2
), 44.0 (CH), 47.1 (CH
2
), 76.3 (CH),
173.5 (C). IR (KBr film) ν
max
/cm-1: 3338, 1610. 14b. mp
63.8-64.4 °C, 1H-RMN (CDCl
3
, 300 MHz) δ 0.87 (3H, d, J
6.6 Hz), 1.02 (3H, d, J 6.6 Hz), 1.11 (3H, dt, J 7.3, 1.5 Hz),
1.65-1.83 (4H, m), 1.90-1.96 (1H, m), 2.47 (1H, dt, J 7.3,
4.4 Hz), 2.91 (1H, bs), 3.22-3.34 (2H, m), 3.41 (2H, q, J 7.3
Hz), 3.93 (1H, bdd, J 8.8, 4.4 Hz). 13C-RMN (CDCl
3
, 75











), 30.0 (CH), 42.1 (CH
2
), 44.8 (CH), 46.9 (CH
2
),
76.6 (CH), 171.7 (C). IR (KBr film) ν
max
 /cm-1: 3423, 1622.
The same procedure was performed using LiHMDS
(LiHMDS was prepared employing HMDS instead of DIPA)
as base affording a 4.4:1 diastereoisomeric mixture of
14a:14b in 60% combined yield.
(1R*,3R*,9aR*)-1-Hydroxy-3-[(1R*)-1-hydroxy-2-
methylpropyl]-1-methylperhydro-4-quinolizinone (16a)
The lithium enolate of 13 was generated as described
above for δ-valerolactam and the reaction with
isobutyraldehyde afforded anti-16a:syn-16b in a 20:1
diastereoisomeric ratio mixture in 85% yield. 16a.
mp:146.0-146.5 °C 1H-RMN (CDCl
3
, 300 MHz) δ 0.91
(3H, d, J 6.6 Hz), 1.05 (3H, d, J 6.6 Hz), 1.25-1.27 (1H, m),
1.34 (3H, s), 1.38-1.45 (3H, m), 1.54 (1H, dd, J 20.1, 13.6
Hz), 1.68-1.76 (1H, m), 1.77-1.86 (2H, m), 1.92-1.97 (1H,
m), 2.41 (1H, bt, J 12.5 Hz), 2.62-2.71 (3H, m), 3.08 (1H,
bdd, J 11.4, 2.6 Hz), 3.61 (1H, dd, J 8.8, 2.9 Hz), 4.81 (1H,
bd, J 11.7 Hz). 13C-RMN (CDCl
3














29.2 (CH), 37.1 (CH
2
), 39.1 (CH), 42.6 (CH
2
), 64.7 (CH),
68.1 (C), 76.4 (CH), 173.8 (C). IR (KBr film) ν
max
 /cm-1:







 (M+•) : 255,1834.
Alternatively, the lithium enolate of 13 was generated
as described for δ-valerolactam. At –78 °C, (iPrOH)
3
TiCl
(3.5 equiv) was added dropwise with stirring over 5 min,
followed by addition of isobutyraldehyde (1.1 equiv) to
gave 32:1 diastereoisomeric ratio mixture of anti-16a:syn-
16b in 58% yield.
(1R*,3R*,9aR*)-1-Hydroxy-3-[(1S*)-1-hydroxy-2-
methylpropyl]-1-methylperhydro-4-quinolizinone (16b)
The lithium enolate of 13 was generated as described
for N-ethylvalerolactam. At –78 °C, TBSOTf (1.0 equiv.)
was added dropwise with stirring and warmed to 0 °C.
After 2 h at 0 °C, isobutyraldehyde (1.1 equiv.) and
TMSOTf (1.1 equiv) were added providing a 1:3
diastereoisomeric ratio mixture of anti-16a: syn-16b in
70% yield. 16b. mp:148.7-149.5 °C 1H-RMN (CD
3
OD, 300
MHz) δ 0.87 (3H, d, J 6.6 Hz), 1.02 (3H, d, J 6.6 Hz), 1.30
(3H, s), 1.35-1.51 (3H, m), 1.55-1.74 (4H, m), 1.79-1.89
(3H, m), 2.48 (1H, dt, J 13.2, 2.6 Hz), 2.74 (1H, ddd, J 12.5,
5.9, 1.8 Hz), 3.14 (1H, dd, J 11.4, 2.6 Hz), 3.30 (1H, quint.,
J 1.5 Hz), 3.94 (1H, dd, J 9.9, 1.8 Hz), 4.71 (1H, bd, J 13.2
Hz). 13C-RMN (CD
3
















), 41.3 (CH), 44.0 (CH
2
), 65.8 (CH), 68.8 (C),
77.4 (CH), 173.4 (C). IR (KBr film) ν
max
 /cm-1: 3400, 3370,







( 1 R * , 9 a R * ) - 1 - H y d ro x y - 1 - m e t h y l - 3 - [ ( E ) - 2 -
methylpropylidene]perhydro-4-quinolizinone (17)
To a solution of the aldol adduct 16a (47 mg, 0.18
mmol) in dry toluene (4.5 mL) was added DCC (46 mg,
0.22 mmol) and CuCl (34 mg, 0.34 mmol), and the resulting
mixture was heated to reflux in a Pyrex tube for 24 h. After
this time, dilute aqueous ammonia (10 mL) was added,
and the mixture was extracted with AcOEt (3x 20 mL). The
organic layer was dried with MgSO
4
 and concentrated under
reduced pressure. The crude was purified through flash
chromatography (petroleum ether:AcOEt, 3:1) to gave (E)-
17 (41 mg, 0.17 mmol) in 95% yield as a colorless oil. 1H-
RMN (CDCl
3
, 300 MHz) δ 1.02 (3H, d, J 6.2 Hz), 1.04 (3H,
d, J 6.2 Hz), 1.28 (3H, s), 1.21-1.36 (1H, m), 1.43-1.71 (3H,
m), 1.85-1.98 (2H, m), 2.47 (1H, d, J 15.0 Hz), 2.44-2.52
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(1H, m), 2.54-2.64 (1H, m), 2.63 (1H, d, J 15.0 Hz), 3.23
(1H, d, J 12.1 Hz), 3.54 (1H, m), 4.82 (1H, dq, J 12.8, 3.0
Hz), 6.81 (1H, bd, J 9.9 Hz). 13C-RMN (CDCl
3



















69.2 (C), 123.6 (C), 148.6 (CH), 163.4 (C). HRMS (EI):






 (M+•) : 237.1729.
( 1 R * , 9 a R * ) - 1 - H y d ro x y - 1 - m e t h y l - 3 - [ ( Z ) - 2 -
methylpropylidene]perhydro-4-quinolizinone (18)
The same procedure was performed using 16b to furnish
18 as the sole product in 95% yield, after column
chromatography eluting with petroleum ether:AcOEt (3:1).
1H-RMN (CDCl
3
, 300 MHz) δ 1.00 (3H, d, J 6.6 Hz), 1.06
(3H, d, J 6.6 Hz), 1.31 (3H, s), 1.36-1.52 (2H, m), 1.65 (2H,
d, J 29.4 Hz), 1.86-2.22 (2H, m), 2.33 (1H, d, J 13.2 Hz),
2.42 (1H, dt, J 13.2, 2.9 Hz), 2.54 (1H, dd, J 13.2, 1.5 Hz),
3.08 (1H, dd, J 11.8, 2.9 Hz), 3.54-3.63 (1H, m), 4.84, (1H,
ddd, J 13.2, 2.9, 1.5 Hz), 5.60 (1H, dd, J 9.9, 1.5 Hz). 13C-
RMN (CDCl
3


















), 66.1 (CH), 68.7 (C), 123.1 (C), 151.6







 (M+•) : 237.1729.
Alternatively, lactam 16b (0.340 g, 1.33 mmol) was
dissolved in dry CHCl
2
 (14.8 mL), with a single crystal of
DMAP, cooled to –40 °C under argon atmosphere, and
treated with trifluoroacetic anhydride (0.565 mL,
4.00 mmol) and 1.00 mL of DBU (6.66 mmol). The reaction
mixture was warmed slowly (over 1 h) to 0 °C, then treated
with a second portion of DBU (1.00 mL, 6.66 mmol) and
allowed to warm to room temperature. Dilute with water
(100 mL) and the mixture was extracted with AcOEt (3x
100 mL). The organic layer was dried with MgSO
4
 and
concentrated under reduced pressure. The crude was
purified through flash chromatography (petroleum
ether:AcOEt, 3:1) to gave (Z)-18 in 80% yield.
N-Ethyl-3-[(E)-2-methylpropylidene]-2-piperidinone
(15a)
The same procedure described for 17 was performed
employing 14a to furnish 15a as the sole product in 88%
yield, after column chromatography eluting with
hexane:AcOEt (1:1). 1H-RMN (CDCl
3
, 300 MHz) δ 0.99
(6H, d, J 6.6 Hz), 1.13 (3H, t, J 7.0 Hz), 1.79-1.87 (2H, m),
2.46 (2H, ddd, J 5.9, 5.9, 1.8 Hz), 2.48-2.60 (2H, m), 3.32
(2H, dd, J 5.9, 5.9 Hz), 3.46 (1H, q, J 7.0 Hz), 6.65 (1H, dt,
J 9.9, 1.8 Hz). 13C-RMN (CDCl
3














), 126.7 (C), 144.5 (CH), 164.7 (C) IR (KBr film)
ν
max





NO (M+•) : 181.1467.
1-Ethyl-3-[(Z)-2-methylpropylidene]-2-piperidinone (15b)
The same procedure described for 17 was performed
employing 14b to furnish 15b as the sole product in 87%
yield, after column chromatography eluting with
hexane:AcOEt (1:1).1H-RMN (CDCl
3
, 300 MHz) δ 0.98
(6H, d, J 6.6 Hz), 1.14 (3H, t, J 7.3 Hz), 1.82-1.90 (2H, m),
2.38 (2H, ddd, J 6.2, 6.2, 1.5 Hz), 3.29 (2H, t, J 6.2 Hz),
3.43 (2H, q, J 7.3 Hz), 3.66 (1H, dq, J 6.5, 2.9 Hz), 5.49 (1H,
bd, J 9.5 Hz). 13C-RMN (CDCl
3














), 126.5(C), 148.0 (CH), 164.8 (C). IV (KBr film)
ν
max





NO (M+•) : 181.1467.
Preparation of lithium aluminum hydride solution in THF
Solution of LiAlH
4
 (5.0 g, 0.125 mol) in THF was
prepared by adding an excess of the hydride to dry THF
(80.0 mL) and stirred the mixture at least 2 h under a dry
argon atmosphere. The resulting solution was then filtered
under a slight positive argon pressure through a 2 cm bed
of tightly packed Celite prepared on a Schlenk system.
After following the above procedure, a crystal-clear 1.55
mol L-1 solution was obtained.
Homopumiliotoxin 223G hydrochloride (1)
To a solution of 18 (30 mg, 0.13 mmol) in THF (1.0 mL)
was added a solution of aluminum hydride (3.0 equiv.,
previously prepared by mixing 1 equiv. of AlCl
3
 and
3 equiv. of LiAlH
4
 solution in THF) at room temperature.
After 10 min, the reaction was quenched with satured
aqueous sodium sulfate solution and filtered. The solids




 and acidified with HCl/MeOH
(10%) to resulting solution effected complete conversion
to hydrochloride salt, and evaporation in reduced pressure
afforded the crude 1 which was purified through flash





(200:90:1). Reacidification with HCl/MeOH afforded pure
1.HCl (0.029 g, 0.11 mmol) 82% yield as pale crystal.
1.HCl. mp:183-184 °C  1H-RMN (CD
3
OD, 500 MHz) δ
0.86 (3H, d, J 6.7 Hz), 0.96 (3H, d, J 6.7 Hz), 1.15 (3H, s),
1.18-1.25 (1H, m), 1.48 (1H, tt, J 13.1, 3.7 Hz), 1.57-1.67
(2H, m), 1.77-1.86 (2H, m), 1.98 (1H, bd, J 14.3 Hz), 2.19
(1H, dd, J 14.3, 1.8 Hz), 2.34 (1H, bd, J 14.0 Hz), 2.53-2.58
(1H, m), 2.93 (1H, dt, J 13.1, 3.4 Hz), 3.05 (1H, dd, J 11.9,
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3.1 Hz), 3.21 (1H, q, J 1.8 Hz), 3.33 (1H, tt, J 13.1, 1.8 Hz),
4.02 (1H, dd, J 13.4, 1.5 Hz), 5.24 (1H, bd, J 9.8 Hz).
13C-RMN (CDCl
3




















), 70.0 (C), 71.0 (CH), 124.1





NO (M+• - HCl) : 223,1936.
(E)-1 Hydrochloride
The same procedure was employed to 17 affording (E)-
1 in 80% yield as a colorless crystal. (E)-1. mp:203-204 °C
1H-RMN (CDCl
3
, 500 MHz) δ 0.93 (3H, d, J 6.2 Hz), 0.95
(3H, d, J 6.2 Hz), 1.26 (3H, s), 1.11-2.00 (5H, m), 2.25-2.62
(2H, m), 2.58-2.70 (1H, d, J 13.0 Hz), 2.99-3.05 (2H, m),
3.18-3.24 (1H, m), 3.43 (1H, bd, J 13.1 Hz), 3.63 (1H, dd, J
13.1, 9.8 Hz), 5.54 (1H, d, J 9.8 Hz). 13C-RMN (CDCl
3
, 75




















), 70.7 (C), 71.8 (CH), 124.8 (C), 141.6 (CH).
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